International Nonalcoholic Steatohepatitis (NASH) Day Sparks New Collaboration for Research
source: pixabay.com

International Nonalcoholic Steatohepatitis (NASH) Day Sparks New Collaboration for Research

International NASH Day, or IND, began in 2018 to raise awareness of nonalcoholic steatohepatitis (NASH). This is the most advanced form of fatty liver disease. It is a progressive condition…

Continue Reading International Nonalcoholic Steatohepatitis (NASH) Day Sparks New Collaboration for Research
June is Scleroderma Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

June is Scleroderma Awareness Month: Spreading Rare Disease Awareness

According to a story from Scleroderma News, June is recognized as Scleroderma Awareness Month. While physical distancing as a result of the ongoing coronavirus/COVID-19 pandemic may keep some folks at…

Continue Reading June is Scleroderma Awareness Month: Spreading Rare Disease Awareness
Portuguese Authorities Approve Treatment for HATTR Amyloidosis Polyneuropathy
source: pixabay.com

Portuguese Authorities Approve Treatment for HATTR Amyloidosis Polyneuropathy

According to a story from PR Newswire, Akcea Therapeutics, Inc. recently announced that the Portuguese Medicine Regulatory Authority (INFARMED) has announced its approval of reimbursement for inotersen (marketed as TEGSEDI®)…

Continue Reading Portuguese Authorities Approve Treatment for HATTR Amyloidosis Polyneuropathy
FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
source: pixabay.com

FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis

In a press release from Eli Lilly and Company, the company has announced recently that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (BLA)…

Continue Reading FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
Filmmaker with Muscular Dystrophy Wins Award for “Muscle Warriors” Documentary
source: pixabay.com

Filmmaker with Muscular Dystrophy Wins Award for “Muscle Warriors” Documentary

  According to Disability Horizons, an extremely talented filmmaker with muscular dystrophy recently won an Award of Recognition from The Best Shorts Film Competition. Stephanie Castelete-Tyrrell's film, entitled Muscle Warriors, documents…

Continue Reading Filmmaker with Muscular Dystrophy Wins Award for “Muscle Warriors” Documentary
NORD Announces Eleven New Grants for Rare Disease Research
source: pixabay.com

NORD Announces Eleven New Grants for Rare Disease Research

According to a story from PR Newswire, the National Organization for Rare Disorders (NORD) has recently awarded a total of eleven new grant awards that will help fund essential research…

Continue Reading NORD Announces Eleven New Grants for Rare Disease Research

Those with Disabilities and Rare Medical Conditions in Canada are Excluded from Financial Relief During Covid-19

Kimberly Underhay Kimberly Underhay is a Canadian who has survived cancer. She has also been diagnosed with osteoarthritis and has to use a walker. Her disabilities have left her unable…

Continue Reading Those with Disabilities and Rare Medical Conditions in Canada are Excluded from Financial Relief During Covid-19
The Very First Treatment for Neurofibromatosis Type 1 Has Been Approved by the FDA
source: pixabay.com

The Very First Treatment for Neurofibromatosis Type 1 Has Been Approved by the FDA

Neurofibromatosis  Neurofibromatosis is a rare condition that presents in different forms. Neurofibromatosis type one (NF1) causes tumors to grow on the plexiform neurofibromas, a type of nerve in the body. These tumors…

Continue Reading The Very First Treatment for Neurofibromatosis Type 1 Has Been Approved by the FDA
NDA to be Submitted for Potential Paroxysmal Nocturnal Hemoglobinuria Treatment
source: pixabay.com

NDA to be Submitted for Potential Paroxysmal Nocturnal Hemoglobinuria Treatment

According to a story from globenewswire.com, the biopharmaceutical company Apellis Pharmaceuticals, Inc. has announced that it is currently making plans to submit a New Drug Application (NDA) to the US…

Continue Reading NDA to be Submitted for Potential Paroxysmal Nocturnal Hemoglobinuria Treatment
Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA
source: pixabay.com

Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA

According to a story from prnewswire.com, the Chiesi Global Rare Diseases and the biopharmaceutical company ProTalix Biotherapeutics have recently announced that they have submitted a Biologics License Application (BLA) for…

Continue Reading Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA